Literature DB >> 29656521

Resveratrol effect on patients with non-alcoholic fatty liver disease: A matter of dose and treatment length.

Federica Fogacci1, Maciej Banach2, Arrigo Francesco Giuseppe Cicero1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29656521     DOI： 10.1111/dom.13324

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN： 1462-8902            Impact factor:   6.577


× No keyword cloud information.
  10 in total

1.  Resveratrol for High Blood Pressure: A Total Failure or the Need to Identify the Right Patient?

Authors:  Federica Fogacci; Silvia Fogacci; Arrigo Cicero
Journal:  High Blood Press Cardiovasc Prev       Date:  2019-07-27

2.  The Effects of Resveratrol Supplementation on Endothelial Function and Blood Pressures Among Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Maryam Akbari; Omid Reza Tamtaji; Kamran B Lankarani; Reza Tabrizi; Ehsan Dadgostar; Fariba Kolahdooz; Mehri Jamilian; Hamed Mirzaei; Zatollah Asemi
Journal:  High Blood Press Cardiovasc Prev       Date:  2019-07-01

3.  Resveratrol Improves Recovery and Survival of Diet-Induced Obese Mice Undergoing Extended Major (80%) Hepatectomy.

Authors:  Xiaoling Jin; Teresa A Zimmers; Zongxiu Zhang; Leonidas G Koniaris
Journal:  Dig Dis Sci       Date:  2018-10-03       Impact factor: 3.199

4.  Usefulness of resveratrol supplementation in decreasing cardiometabolic risk factors comparing subjects with metabolic syndrome and healthy subjects with or without obesity: meta-analysis using multinational, randomised, controlled trials.

Authors:  Consolato Sergi; Bonnie Chiu; Joseph Feulefack; Fan Shen; Brian Chiu
Journal:  Arch Med Sci Atheroscler Dis       Date:  2020-05-30

5.  Efficacy and Safety of Armolipid Plus®: An Updated PRISMA Compliant Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.

Authors:  Arrigo F G Cicero; Cormac Kennedy; Tamara Knežević; Marilisa Bove; Coralie M G Georges; Agnė Šatrauskienė; Peter P Toth; Federica Fogacci
Journal:  Nutrients       Date:  2021-02-16       Impact factor: 5.717

Review 6.  Autophagy in Hepatic Steatosis: A Structured Review.

Authors:  Vitor de Miranda Ramos; Alicia J Kowaltowski; Pamela A Kakimoto
Journal:  Front Cell Dev Biol       Date:  2021-04-15

7.  Efficacy and Safety of Resveratrol Supplements on Blood Lipid and Blood Glucose Control in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Tianqing Zhang; Qi He; Yao Liu; Zhenrong Chen; Hengjing Hu
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-24       Impact factor: 2.629

Review 8.  Implications of Resveratrol in Obesity and Insulin Resistance: A State-of-the-Art Review.

Authors:  Thomas M Barber; Stefan Kabisch; Harpal S Randeva; Andreas F H Pfeiffer; Martin O Weickert
Journal:  Nutrients       Date:  2022-07-13       Impact factor: 6.706

9.  Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence.

Authors:  Arrigo F G Cicero; Alessandro Colletti; Stefano Bellentani
Journal:  Nutrients       Date:  2018-08-23       Impact factor: 5.717

Review 10.  The Role of Resveratrol in Liver Disease: A Comprehensive Review from In Vitro to Clinical Trials.

Authors:  Carmine Izzo; Monica Annunziata; Giuseppe Melara; Roberta Sciorio; Marcello Dallio; Mario Masarone; Alessandro Federico; Marcello Persico
Journal:  Nutrients       Date:  2021-03-13       Impact factor: 5.717
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.